業績|論文・出版物|目次|
2023
Establishment of UGT1A1-knockout human iPS-derived hepatic organoids for UGT1A1-specific kinetics and toxicity evaluation.
Shintani T.#, Imamura C.#,?Ueyama-Toba Y.,?Inui J., Watanabe A.,?Mizuguchi H. #These authors equally contributed to this work.
Mol. Ther. Methods Clin. Dev., 30, 429-442 (2023)
(外部サイトへリンク)
Quantitative analysis of mRNA and protein expression levels of aldo-keto reductase and short-chain dehydrogenase/reductase isoforms in the human intestine.
Hirosawa K., Fujioka H., Morinaga G., Fukami T., Ishiguro N., Kishimoto W., Nakase H., Mizuguchi H., Nakajima M.
Drug Metab Dispos., 51, 1569-1577 (2023)
(外部サイトへリンク)
Novel conditionally replicating adenovirus-mediated efficient detection of circulating tumor cells in lung cancer patients.
Ikemoto S., Sakurai F., Tokuoka S., Yamashita T., Takayama K., Hoshi K., Okabe T., Sumiyoshi I., Togo S., Takahashi K., Tachibana M., Mizuguchi H.
PLoS ONE, 18, e0286323 (2023)